National Bank of Canada’s Baird Medical Investment Holdings BDMD Stock Holding History

National Bank of Canada’s Portfolio BDMD Stock Details BDMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.3K	Hold	11,700	–	–	﹤0.01%	2153
2025 Q4	$15.8K	Buy	+11,700	New	+$17K	﹤0.01%	2206

Other funds holding BDMD

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

National Bank of Canada's BDMD Position: Q1 2026 in Review

National Bank of Canada held its Baird Medical Investment Holdings (BDMD) position steady in Q1 2026 at 11,700 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

National Bank of Canada first reported a position in BDMD in Q4 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold BDMD as of Q1 2026.

National Bank of Canada held 11,700 shares of Baird Medical Investment Holdings worth $22.3K as of Q1 2026.
National Bank of Canada left its Baird Medical Investment Holdings share count unchanged in Q1 2026.
Baird Medical Investment Holdings made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2153 holding.
National Bank of Canada first reported a position in Baird Medical Investment Holdings in Q4 2025 and has held it in 2 quarters since.
8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.